Experimental autoimmune encephalomyelitis (EAE) in rats is a highly valuable model of multiple sclerosis (MS) since it mimics major hallmarks of the human disease. EAE induced with myelin-oligodendrocyte-glycoprotein (MOG) in DA rats is relapsingremitting and lesions in the central nervous system show inflammation, demyelination, axonal and neuronal loss. Recently, bone marrow transplantation (BMT) was introduced as a novel strategy to treat MS but its efficiency and the underlying mechanism are debatable. In MOG induced EAE we found that BMT at the peak of EAE but not in the chronic phase leads to disease attenuation. In both settings bone marrow (BM) transplanted rats were protected from subsequently induced relapses. These findings could be confirmed by histopathology in which BM transplanted rats did not have lesions compared to non-transplanted controls. Importantly, the protective effect was achieved by allogeneic, syngeneic and grafts from diseased rats. BMT resulted in increased numbers of CD4+CD25bright regulatory T cells, increased Foxp3 expression, a shift in T cell epitope recognition and a strong reduction of autoantibodies even after re-challenge with MOG. Thus, our results indicate potential mechanisms of how BMT may contribute to the improvement of MS and provide a rationale for its application in patients suffering from various autoimmune diseases.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) which is characterized by demyelinating plaques and axonal loss 1 . Although MS is highly prevalent in northern Europe and the USA 2 there is presently no cure available and the clinical management of the disease is unsatisfactory 1 . The etiology of MS is unknown. However, it is generally believed that both genetic and environmental factors contribute to the development of its pathology 3 . The onset of MS is presumably characterized by autoreactive T cells crossing the blood brain barrier (BBB) and initiating an inflammatory response which results in an opening of the BBB.
This allows influx of additional immune cells such as granulocytes, macrophages, NK cells and B cells, as well as antibodies and complement 4 . Subsequently, this process leads to myelin destruction, induction of oligodendrocyte death, axonal degeneration and ultimately to the functional deficits seen in MS patients 5 . Experimental autoimmune encephalomyelitis (EAE) is a frequently used animal model for MS which can be induced in rodents and monkeys 6 . In particular, myelin-oligodendrocyte-glycoprotein (MOG) induced EAE in DA rats mimics major hallmarks of the human disease. These include the relapsing/remitting type of disease course, the occurence of demyelinated plaques in brain and spinal cord, axonal loss, and the involvement of both antibodies and complement in the pathogenesis [7] [8] [9] [10] [11] .
Autologous bone marrow transplantation (BMT) and hematopoietic stem cell transplantation (HSCT) are presently discussed as novel options for the treatment of patients with MS with fast progressive disease courses that do not respond to conventional treatment 12, 13 . Clinical trials were to some extent inconclusive since they arrived at divergent results [14] [15] [16] . Preclinical studies were performed in EAE that
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From assessed certain aspects of BMT like timing and source of grafts to some extent in rats and mice [17] [18] [19] [20] [21] [22] [23] [24] . In order to lay further ground for clinical studies we conducted BMT using MOG induced EAE in the rat. We performed all possible combinations of BMT in susceptible DA and resistant ACI rats that share the RT1 av1 haplotype (RT1 is MHC in rats) 8 . Also, we analyzed the effect of BMT in acute versus chronic disease and the specificity of the protection after BMT in this model. Importantly, we were able to investigate the immunological mechanisms operative during BMT regarding the T cell recognition, autoantibodies and T regulatory cells in the treatment of EAE. This allows us to suggest a strategy of how BMT could be most efficiently employed in the therapy of MS and how clinical markers could be defined to assess treatment success.
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Materials and Methods

Rats
Female rats, 10-14 weeks of age, were used in all experiments. DA rats were obtained from Harlan Winkelmann (Borchen, Germany) and ACI rats from Harlan USA (Indiana, IN). Rats were kept under specific pathogen free (SPF) conditions and obtained food and water ad libitum. Generation and characterization of GFP-transgenic Lewis rats 25 (line UGC) have been described elsewhere. All animal experiments were approved by the regional boards in Tübingen and Würzburg, Germany.
Synthetic peptides and antigens
MOG 73-90 (KESIGEGKVALRIQNVRF), MOG 91-108 (SDEGGYTCFFRDHSYQEE)
and MBP 63-88 (HTRTTHYGSLPQKSQRTQDENPVVHF) were prepared by Karl-Heinz Wiesmüller, (EMC microcollections, Tübingen, Germany) by solid phase peptide synthesis using F-moc/tBu chemistry. Peptides were purified by preparative HPLC (Abimed, Langenfeld, Germany). The identity of the purified peptides was confirmed by electrospray mass spectrometry. The purity of peptides was >95% as determined by analytical HPLC (Abimed). Recombinant rat MOG, corresponding to the N-terminal sequence of MOG (amino acids 1-125, MOG 1-125) was expressed in Escherichia coli and purified. The purified protein in 6 M urea was dialyzed against PBS and stored at -20°C.
BMT
For TBI 6 MV photons at a dose rate of approximately 1 Gy/min delivered from a linear accelerator (Elekta, Hamburg, Germany) were used. Rats were irradiated with a lethal 
Blood cell enumeration
To assess reconstitution of cell lineages in transplanted rats blood samples from the tail vein were analyzed in an automated blood analyzer (VetABC, Scil, Viernheim, Germany).
Induction and scoring of EAE
EAE was induced by administration of 200 µl inoculum intradermally at the base of the tail. The inoculum consisted of 50 µg MOG 1-125 in PBS emulsified with CFA (Sigma) which died after the transplantation procedure were excluded from the experiment and rats that died of EAE after reimmunization were scored with a score of 4.
Isolation of mononuclear cells (MNC) from lymph nodes (LN) and spleens
Draining inguinal LN and spleens were dissected out under deep anaesthesia. LN were antigen was added to the plates and incubated for 48 h at 37°C in a humidified atmosphere containing 5% CO 2 . For each Ag, triplicate determinations were performed.
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From MOG 1-125 was used at a concentration of 3 µg/ml and peptide at a concentration of 10 µg/ml. ConA was purchased from Sigma (St. Louis, MO) and used at a concentration of 1 µg/ml. Cells were discarded, and plates were washed four times with PBS. Secreted and bound IFN-γ was visualized with biotinylated DB12 mAb against rat IFN-γ (also a generous gift of Peter van der Meide), avidin-biotin peroxidase (Vector Laboratories, Burlingame, CA), and subsequently by staining with carbazole (Sigma).
ELISA
Blood samples for antibody measurements were taken at the end of experiments. ELISA plates (96 well; Nunc, Roskilde, Denmark) were coated with 2.5 µg/ml (100 µl/well) MOG 1-125 overnight at 4°C. Plates were washed with PBS/0,05% Tween 20 and blocked with milk powder for 1 h at room temperature. After washing, diluted serum samples were added and plates were incubated for 1 h at room temperature. Then, plates were washed and rabbit anti rat antiserum (IgG, IgG1, IgG2a, IgG2b, IgG2c, Nordic, Tilburg, The Netherlands) was added and incubated for 1 h at room temperature. Plates were washed prior to the addition of peroxidase conjugated goat anti rabbit antiserum (Nordic) diluted in PBS/0.05% Tween 20. After 30 min incubation, plates were washed and bound Abs were visualized by addition of ABTS (Roche Diagnostics Mannheim, Germany). After 15 min of incubation optical density was read at 405 nm.
Quantitative real time RT PCR
Total RNA was extracted from splenocytes using RNeasy Mini Kit (Qiagen, Hilden, Germany Cells were gated on the lymphocyte population in the FSC-SSC dot plot.
Enrichment of CD4+ CD25+ T cells.
A single cell suspension of MNC from spleens was obtained as described above. The 6 of these cells were injected i.v. into recipient rats.
Histopathological evaluation
Histological evaluation was performed on paraformaldehyde fixed, paraffin embedded sections of brains and spinal cords. Paraffin sections were stained with hematoxylin and eosin, Luxol fast blue, and Bielschowsky silver impregnation to assess inflammation, demyelination, and axonal pathology, respectively as described [8] [9] [10] .
Immunohistochemistry was performed using a modified avidin-biotin-based technique using diaminobenzidine as chromogen 27 . After microwave pretreatment, sections were incubated over night with antibodies against ED1 (Serotec), CD3 (Serotec), rat immunoglobulin (Amersham), rat C9 (kindly provided by BP Morgan, University of Cardiff, UK) and APP (Chemicon) followed by appropriate biotinylated secondary antibodies (Amersham). Sections incubated without primary antibody, with iso-type control antibodies and with pre-immune sera did not show any immunoreactivity.
Sections were counterstained with haemalaun.
Data analysis
Statistical significance was tested by students t-test or ANOVA as indicated. 
Results
Chimerism and engraftment
We chose DA and ACI rats as a source for the BM grafts since these rat strains are MHC matched (RT1 av1 ) while differing in their non-MHC genome and their susceptibility to MOG 1-125 induced EAE: DA rats are EAE susceptible while ACI rats are resistant 8, 28 . We determined the degree of engraftment of donor BM after BMT on day 107 after transplantation. In order to differentiate between cells of ACI or DA rat origin we analyzed the relative intensity of a microsatellite marker in a quantitative PCR reaction of transplanted rats. DA rats with ACI BM (n=6) had a high percentage of cells with the ACI allele in their blood (96.9%+/-0.55), while the ACI allele in the blood of ACI rats with DA BM (n=8) was low (5.1%+/-1.19) ( Figure 1A ). We determined the number of leukocytes, platelets and erythrocytes as well as hematocrit and hemoglobin concentration in BM transplanted DA rats on day 107 post transplantation. We did not detect any difference compared to non transplanted animals except for the leukocyte counts (P=0.0014, ANOVA) confirming complete reconstitution of the recipient rats (Table 1) .
To further verify the quality of the transplantation procedure we transplanted BM from eGFP transgenic LEW rats 25 into syngeneic LEW rats (n=16). Susceptibility to MBP 63-88 induced EAE was unchanged in LEW rats reconstituted with GFP transgenic BM (n=5) compared to naïve LEW rats (n=5) ( Figure 1B ). We confirmed the successful reconstitution of host lymphatic tissues (lymph nodes, thymus) and BM using our grafting protocol ( Figure 1C ). LN cells in LEW rats transplanted with BM from eGFP transgenic LEW rats were comparable in GFP expression compared to naïve eGFP transgenic LEW rats (pool of n=5 naïve eGFP transgenic LEW rats, LEW rats transplanted with BM from eGFP transgenic LEW rats n=5). Cells eluted from the CNS For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From in the course of EAE were also highly GFP-positive ( Figure 1D ).
BMT studies in naïve rats
DA rats develop a relapsing/remitting disease course after immunization with MOG 1-125 (n=5). To address the question whether BMT by itself alters the susceptibility to EAE we performed total body irradiation (TBI) with 10 Gy in naïve DA rats and transplanted them with DA BM (n=4). On day 60 post BMT after BM reconstitution, rats were immunized with MOG 1-125. Similar to rats which had not received BMT, the disease course in these transplanted rats was of the relapsing/remitting disease type 
Effects of BMT on established disease and induced relapses
To evaluate the effect of TBI and subsequent BMT on EAE we divided DA rats in three groups: DA rats grafted with DA BM, DA rats grafted with ACI BM and not irradiated ungrafted DA rats. At the peak of acute disease on day 17 post immunization (p.i.), rats In order to investigate whether BMT also had a positive effect on the disease course when performed in the chronic phase of EAE, we chose a later time point (day 140 p.i.)
for BMT. Interestingly, we did not observe any improvement of EAE after transplantation with DA BM (n=9) in this setting. To further evaluate whether rats were protected from following relapses under these conditions we reimmunized with MOG 1-125 them after reconstitution (day 181 p.i.). While we were able to demonstrate partial improvement of EAE using this protocol (n=4), protection induced by BMT in the chronic phase was slightly weaker as compared to the situation when BMT was performed at the peak of Figure 3B ).
Histopathology
We performed a histopathological examination of brains and spinal cords at the end of the experiments ( Figure 3A and repetition of experiment). 13 out of 15 DA rats without BMT had strong inflammation and widespread demyelination in the CNS (Figure 4A-H) .
In contrast only three out of 14 DA rats treated with DA BM and none of the eleven DA rats treated with ACI BM showed inflammation or/and demyelination in the CNS ( Figure   4I -O). Lesion pathology in untreated animals was characterized by large, confluent demyelination ( Figure 4A ), macrophage infiltration ( Figure 4B ) and deposition of immunoglobulin and C9 indicative of antibody mediated demyelination (Fig. 4C, D) . 
Syngeneic BMT with BM from diseased rats
To mimic the clinical setting more closely we conducted an experiment in which rats were treated in the acute phase of EAE with syngeneic BM of rats with EAE. This transplantation regimen led to an amelioration of the disease course (n=9) as compared to those which had not been transplanted (n=9) ( Figure 5A ). Syngeneic BM from rats with EAE also protected from induced relapses with MOG 1-125 ( Figure 5B 
org From
Antigen specificity of the protection from EAE mediated by BMT All our experiments described so far suggested that protection from EAE is due to induction of tolerance to MOG induced EAE relapses. In order to assess whether protection is antigen specific, we rechallenged rats that had received a DA BM transplant from DA rats with EAE at the peak of MOG-EAE with the immunodominant MBP 63-88 peptide (n=4) ( Figure 5C ). As controls, rats that were BM transplanted as naïve rats were challenged with MBP 63-88 (n=4). Both groups were not protected against MBP 63-88 induced EAE ( Figure 5C ). These results indicate that the tolerance achieved by BMT is specific for the antigen used to induce disease.
Autoantibodies
Antibodies against MOG play an important role in mediating widespread demyelination in DA rats 11 . Therefore we assessed total IgG levels against MOG 1-125. Upon immunization the antibody levels increased to MOG (n=6) compared to naïve controls (n=4) (P<0.002). On day 123 p.i., 107 day after BMT, DA rats transplanted with DA BM (n=8) and DA rats transplanted with ACI BM (n=6) showed a strong reduction of autoantibody titers compared to the non transplanted control group with EAE (n=8) (P=0.0001). This effect was even more pronounced on day 154 p.i. post re-immunization (no BMT n=6; DA BM n=6, ACI BM n=5) (P<0.0001) ( Figure 6A ).
To test whether BMT by itself leads to a reduced antibody response we measured serum antibody levels in rats which were transplanted as naïve rats and immunized with MOG 1-125. These rats developed an antibody response comparable to rats without BMT and significantly higher than the rats transplanted during acute EAE (P<0.0001) ( Figure 6A ). Figure 6B ). Based on the isotype distribution, we did not find evidence for a Th2 shift.
Lymphocyte subset distribution
To evaluate whether differences in the lymphocyte subset distribution between EAE 
T cell responses towards MOG peptides
We used the elispot method for quantification of MOG specific IFN-γ producing cells. Figure 6F ). 
Encephalitogenicity of MOG 73-90 and MOG 91-108 peptides
Induction of T cells with a regulatory phenotype by BMT
Finally, cytofluorometric analysis of CD25 expression of CD4+ T cells in LN revealed
that CD4+CD25bright cells were increased in DA rats transplanted with either DA BM (n=6) or ACI BM (n=6) compared to not transplanted rats (n=8) (P<0.01, ANOVA) ( Figure 7A,B) . Also the mRNA of transcription factor Foxp3 was increased in lymphocytes from spleen of BM transplanted rats (n=7) compared to controls 
Discussion
Autologous BMT is a novel option for treatment of fast progressive patients with MS but initial clinical trials have proven inconclusive [14] [15] [16] . Even though there have been a number of studies regarding BMT in EAE 17-24 , our studies on BMT therapy in a well characterized animal model for MS represent a comprehensive analysis of this innovative therapy and provide a mean to investigate its characteristics in detail with regard to the timing of BMT, the source of the graft and, the mechanisms of its action.
MOG induced EAE in rats is currently one of the best models for MS since it largely reproduces the immunological complexity of MS which is characterized by a combination of T cell mediated effector mechanisms, the action of autoantibodies, macrophages and NK cells in lesion development 11 . In this sense MOG induced EAE in DA rats used in our studies contrasts purely T cell mediated models, e.g. T cell transfer studies, widely used for investigations on mechanisms operating in MS and BMT 24, 30, 31 . The similarity of our model to MS is shown in histopathology where widespread demyelination and axonal loss are found [8] [9] [10] . In this study we also show by histopathology large demyelinated plaques and axonal pathology with the presence of T cells, macrophages, antibodies and complement factors. Therefore the model described here can be considered to be highly relevant for the preclinical testing of novel strategies for the treatment of MS. Furthermore it might contribute to a better understanding of the pathogenesis of MS 29, [32] [33] [34] .
In agreement with earlier studies we demonstrate that BMT leads to disease attenuation and protects from further induced relapses with the disease inducing antigen, strongly suggesting that this therapy is a promising option for the treatment of MS in humans [17] [18] [19] [20] [21] [22] [23] [24] . For the first time we demonstrate in direct comparisons that protection can be 16, 24 . Importantly, in the acute and chronic phase of the disease BMT prevented subsequently induced relapses. For BMT in the acute phase of EAE this has been shown before 18, 23 . BMT in the chronic phase and subsequent demonstration of protection from relapses has not been shown before. We conclude that BMT in clinical trials should be preferentially performed at peak of disease while it is still worth considering also in later stages of disease progression as long as inflammatory activity is present.
As to the mode of action of BMT, three novel interconnected mechanisms for protection could be found: i) induction of CD4+CD25bright regulatory T cells; and ii) an increased reactivity of T cells responsive to a non-encephalitogenic determinant, namely MOG 73-90; and iii) reduced autoantibody levels.
T cell tolerance is achieved by positive and negative selection in the thymus, peripheral induction of anergy and by the action of regulatory T cells 35 . Our data using MBP 63-88
for rechallenge in MOG induced EAE suggests that the protection from EAE conferred by BMT is specific for the disease inducing antigen and not a general immunosuppressive effect. CD4+CD25+ regulatory T cells play an important role in the maintenance of immune tolerance to self 36 . CD4+CD25+ cells have an antigen specific regulatory function in vivo in EAE 37 . By transfer studies we show that CD4+CD25+ cells are also protective when transferred in naïve rats. Further studies regarding the role of regulatory T cells in EAE and BMT are ongoing in our laboratory. In the present study
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From we demonstrate increased numbers of CD4+CD25bright T cells in rats after BMT as compared to non transplanted control rats. Foxp3 is a transcription factor which is necessary for the function of these regulatory T cells 38 . Male scurfy mice with a mutation in Foxp3 and Foxp3 knockout mice develop a lethal lymphoproliferative disorder stressing the importance of this gene in immune homeostasis 38, 39 . Foxp3 acts as a T regulatory cell lineage specification factor and mediator of the genetic mechanisms of dominant tolerance 40 . We observed an increased expression of Naïve irradiated and DA rats transplanted with BM from resistant ACI rats were not protected from disease induction and also BM from resistant rats transplanted in
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From resistant rats did not protect from EAE. This data in connection with BMT studies in established EAE clearly shows that specific protection is only achieved in the context of ongoing inflammation and suggests that availability of the autoantigen during reconstitution of the immune system is important for subsequent protection. MOG-EAE resistant ACI rats become susceptible when irradiated and BM either ACI or DA rat origin is transplanted in a naïve state. These data reinforces the concept that autoantigen or mimicking antigens need to be present during the establishment of tolerance 44 . Furthermore impaired homeostasis could be of great importance and lead to increased disease susceptibility in non-diseased transplanted rats 37, 41 . Reduction of numbers of regulatory cells could be a further factor affecting susceptibility in naïve BM transplanted rats. MOG is sequestered behind the BBB in the CNS as immunoprivileged site and not easily accessible to the immune system 11 . The fetal and postnatal period during which orchestrated gene expression of most self antigens takes place is necessary for long lasting tolerance induction to various autoantigens 45 . Obviously the same quality of tolerance can not be achieved after BMT in adult life. Therefore, we
propose that the eradication of lymphocytes after irradiation leads to an altered thymic output in the adult rat in context with inflammation and the exposure to autoantigen which leads to the induction and production of regulatory T cells with the ability to suppress EAE. Importantly, it has to be considered in the clinical therapy that BMT, even though effective in the context of a specific autoimmune disease, could therefore result in increased susceptibility to other autoimmune diseases.
We found a reduction of the CD4 compartment in transplanted rats. This was an effect of the transplantation procedure since we measured the same reduction in rats that had been transplanted in the naïve state as compared to rats that had been transplanted in Others have analyzed the influence of BMT on the T cell repertoire and on autoantigen specific T cell responses 46, 47 . Recently it was shown that BMT in humans can change the TCR repertoire 47 . In another study a transient reduction and change in MBP specific T cell responses to different MBP determinants after BMT could be demonstrated 46 . We by guest
